当前位置: X-MOL 学术J. Pediat. Inf. Dis. Soc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Preexisting Heterotypic Ligand-blocking Antibody Does Not Protect Against Genogroup II Norovirus Episodes in Young Children.
Journal of the Pediatric Infectious Diseases Society ( IF 2.5 ) Pub Date : 2022-10-25 , DOI: 10.1093/jpids/piac063
Sylvia Becker-Dreps 1, 2 , Paul D Brewer-Jensen 2 , Fredman González 3 , Yaoska Reyes 3, 4 , Michael L Mallory 2 , Lester Gutiérrez 3, 4 , Nadja A Vielot 1 , Marta Diez-Valcarce 4, 5 , Jan Vinjé 4 , Ralph S Baric 2 , Lisa C Lindesmith 2 , Filemon Bucardo 3
Affiliation  

A birth cohort design was used to understand whether heterotypic ligand-blocking norovirus antibodies provide cross-protection within the GII genogroup. We found that almost one-half of children who experienced a norovirus GII episode had preexisting antibodies heterotypic to the infecting genotype; therefore, these antibodies did not provide cross-protection.

中文翻译:

预先存在的异型配体阻断抗体不能预防幼儿中的基因组 II 诺如病毒发作。

使用出生队列设计来了解异型配体阻断诺如病毒抗体是否在 GII 基因组内提供交叉保护。我们发现,几乎一半经历过诺如病毒 GII 感染的儿童体内预先存在与感染基因型异型的抗体;因此,这些抗体不提供交叉保护。
更新日期:2022-07-18
down
wechat
bug